Companies Related to "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia" [Most Relevant Company Matches] - Page: 3 RSS

16:28 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia" found in our extensive corporate database of over 50,000 company records.

Showing "Bortezomib Dexamethasone Rituximab Previously Untreated Patients With Waldenstrom" Companies 51–75 of 4,000+

Probably Relevant

Taxolog, Inc.,

Taxolog, Inc., was co-founded in 1997 by Drs. Robert A. Holton and Lewis L. Metts. The mission of the company is to develop and commercialize unique drugs based on pharmacologically powerful taxanes for the treatment of cancer and other diseases. Taxolog is headquartered in Fairfield, N.J., with an additional state-of-the-art facility in Tallahassee, Fla., employing more than 40 executive and scie...

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. ...

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patie...

NeoChord, Inc.

Based in Eden Prairie, Minn., NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company received CE marking in Dec. 2012 for the DS1000 device for minimally invasive mitral valve repair via surgical implantation of artificial chordae tendinae. Degenerative mitral regurgitation occurs whe...

NeoChord Inc.

Based in Eden Prairie, Minn., NeoChord is a privately held medical technology company focused on advancing the treatment of mitral regurgitation. The Company expects to commercialize a surgical device for minimally invasive mitral valve repair via surgical implantation of artificial chordae tendinae. Degenerative mitral regurgitation occurs when the leafle...

Ironshore Pharmaceuticals & Development, Inc.

Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Highland Therapeutics Inc., is a pharmaceutical company that is leveraging its proprietary technology, DELEXIS®, to optimize the delivery of previously approved drug products.

Novadel Pharma, Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company that previously developed oral spray formulations of marketed pharmaceutical products. The Company has discontinued its operations.

Miracor Medical Systems GmbH

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The ...

NeoMPS, Inc.,

NeoMPS, Inc., previously known as Multiple Peptide Systems (MPS), is a privately held company, based in San Diego, specializing in custom research and pharmaceutical grade peptides, antipeptide antibodies, bioactive peptides, modified amino acids, building blocks and turn mimics. NeoMPS, Inc. is part of GROUPE SNPE (Paris, France).


Genitope Corporation is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. Immunotherapy products are designed to utilize the immune system to combat diseases such as cancer. Our lead product candidate, MyVax® Personalized Immunotherapy (previously referred to as GTOP-99) is currently in a pivotal Phase 3 trial for the treatment o...

Euthymics Bioscience, Inc.

DOV is a biopharmaceutical company historically focused on the development of novel product candidates for disorders of the central nervous system. DOV has previously funded drug development and discovery programs that are now at the preclinical, Phase I and Phase II clinical stages focused on monoamine reuptake inhibitors.

R-Tech Ueno, Ltd.

R-Tech Ueno is a bio-venture company established in September 1989 for the purpose of marketing and R&D of drugs. Under leadership of the president, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent.

Patients and Physicians for Rx Access

Patients and Physicians for Rx Access is a coalition consisting of individual patients, patient advocacy groups, pharmacists, physicians, pharmacies and healthcare organizations working to save patient access to compounded medications. The coalition formed to protect patients from the immediate threat from a growing number of pharmacy benefit managers and ...

Via Radiology

Via Radiology, previously known as Western Radiology Associates, was established in 1969. For the last forty eight years, it has been a leader in delivering state-of-the-art imaging services to north King and south Snohomish counties. Via Radiology is comprised of a group of highly specialized and experienced, board-certified radiologists, whose skills run...

Quanterix Corporation

Quanterix is a developer of ground-breaking tools in high definition diagnostics. Its Simoa platform uses single molecule measurements to access previously undetectable proteins. With this unprecedented sensitivity and full automation, Simoa offers significant benefits to both research and clinical testing applications. Quanterix was established in 2007 an...

Scientific Asset Management, LLC

Scientific Asset Management or SAM Buys, Sells, Trades and Brokers Previously Owned Laboratory Instruemtnation around the globe. Assets originally sold buy such companies as Beckman, Sorvall, Hewlett-Packard, Ageilent, ABI, Perkin Elmer, Waters, Millipore to name a few. We buy for a single asset to complete buildings or companies. Please contact us with your request.

OmniTier Inc.

OmniTier develops and supports integrated software solutions to accelerate data-intensive infrastructure applications, including high performance object (K-V) caching, scientific analysis for machine learning and AI, and genome assembly in bioinformatics. Founded in February 2015, the company has R&D operations in Milpitas, CA and Rochester, MN. The OmniTi...

Stayhealthy, Inc.

Stayhealthy, Inc. distributes home-use monitoring devices and is working with IBM on network-ready health kiosks. Stayhealthy's products allow users to quickly and accurately monitor health.Our CompanyStayhealthy, Inc. was launched in 1995 as one of the first healthcare websites. Since then, we have developed the first of a line of health-related products and services that use state-of-the-art tec...

i-Human Patients (IHP)

i-Human Patients, Inc. develops educational and competency assessment technology for the health care professional market, including its flagship i-Human Patients® platform, launched in November 2012. Cloud-based and interactive, the i-Human case player improves and evaluates competencies using active learning strategies and content developed by almost 1...

Decision News Media SAS

We are a science and industry News specialist and deliver our news services as free-access websites and daily newsletters.All our sites are written by award-winning journalists. They scan available scientific, technical and industry sources and search out previously unpublished material, primary data and expert opinions in all areas of significance to decision-makers among our target audience.

CLRS Technology Corporation

Established in 2007, CLRS Technology is a manufacturing company that specializes in development of innovative and clinically proven consumer hand-held medical devices that deliver at-home solutions for common skin and allergy problems that were previously only available at a medical or aesthetic professional's office. More information about CLRS Technology and the CLARO IPL Acne Clearing Device c...


PhotoPharmics is a privately-held, clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the eyes. Company founders have 30+ years of research and experience in this field. They previously developed specialized light solutions now widely used to regulate circadian rhythms for seasonal a...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...


Plan2Account is an asset recovery company helping a national client base of healthcare providers collect on trapped assets. Through a combination of innovative software and experienced staff, Plan2Account successfully works against the Payor to identify underpayments and retrieve previously irretrievable debt both today and in the future. To date, P2A has ...

Biotech Synergy

Biotech Synergy has secured in San Diego the necessary competences to bring this promising multi epitope cancer vaccine to latest stage development. Contrary to Dendreon individualized vaccine, EP-2101 is made of 10 peptides and is an off the shelf readily available vaccine for the HLA-A2 population, which represents 45% of the global NSCLC patients (100,0...

More From BioPortfolio on "Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia"

Quick Search


Corporate Database Quicklinks